Summary. A time-specific log-linear regression method on quantile residual lifetime is proposed. Under the proposed regression model, any quantile of a time-to-event distribution among survivors beyond a certain time point is associated with selected covariates under right censoring. Consistency and asymptotic normality of the regression estimator are established. An asymptotic test statistic is proposed to evaluate the covariate effects on the quantile residual lifetimes at a specific time point. Evaluation of the test statistic does not require estimation of the variance-covariance matrix of the regression estimators, which involves the probability density function of the survival distribution with censoring. Simulation studies are performed to assess finite sample properties of the regression parameter estimator and test statistic. The new regression method is applied to a breast cancer data set with long-term follow-up to estimate the patients' median residual lifetimes, adjusting for important prognostic factors.
Introduction
In medical research, an investigator's ultimate interest may be in inferring the remaining life years of a patient, given his/ her genetic and/or environmental backgrounds. The remaining life years of a patient could be prolonged by treating or preventing a disease by a medical intervention. Existing statistical methods such as an adjusted version of the KaplanMeier method (Kaplan and Meier, 1958) or Cox proportional hazards model (Cox, 1972 (Cox, , 1975 may be adopted to indirectly infer the remaining lifetimes, but they are often cumbersome and not straightforward, especially when the remaining lifetimes need to be evaluated in the middle of an observation period. Also the remaining lifetimes at a specific time point estimated from the semiparametric models such as proportional hazards or accelerated failure time (AFT) (Cox and Oakes, 1984) may heavily depend on model assumptions that affect the entire observation period. Another advantage of using the concept of the remaining lifetime is that it may provide investigators and patients with more straightforward interpretations regarding the efficacy results from clinical studies, so that they can communicate more clearly about potential benefits of new drugs for ongoing or future trials.
Some recent phase III breast cancer clinical trials provide practical examples of studies that could take advantage of the proposed method (Goss et al., 2003; Coombes et al., 2004; Mamounas et al., 2008) . In those studies, estrogen receptorpositive patients who had been treated with tamoxifen for up to 5 years without recurrence of the original disease were re-randomized to placebo or an aromatase inhibitor, either letrozole or exemestane. A patient who would be interested in participating in this type of study would want to know how much her lifetime could be extended by accepting the new therapy after she had already survived 5 years since her initial diagnosis and treatment. In this case, the important covariates to be included in a regression model would be the patient's age at diagnosis, seriousness of nodal involvement, status of estrogen or progesterone receptor, pathological tumor size, and type of the initial therapy.
Quantile regression models were originally introduced by Koenker and Bassett (1978) . Recent developments in this area for non-censored data include Jung (1996) , Portnoy and Koenker (1997) , Wei et al. (2006) , Whang (2006) , and Mu and He (2007) . Jung (1996) implemented the quasi-likelihood approach to obtain the parameter estimates for median regression models, which allows for the observations to be dependent. Portnoy and Koenker (1997) introduced a new computational technique that permits a faster estimation process for general l 1 -type problems over the widely used simplex method for sufficiently large sample sizes. Wei et al. (2006) applied the quantile regression approach to analyze longitudinal growth charts data. Whang (2006) proposed to use the empirical likelihood approach for parameter estimation and construction of the confidence regions. Mu and He (2007) developed the power-transformed linear quantile regression model by using the equivariance property of the quantiles under monotone transformations.
For censored data, although much work has been done on the quantile regression model at the origin of the time axis, not much attention has been given to the regression model on quantile residual life function. Gelfand and Kottas (2003) proposed a Bayesian inference procedure for a median residual life regression model that was derived by the AFT regression model. Their work relies on correct specification of the AFT model for the underlying failure time distribution. In this article, we develop a frequentist and time-specific regression method that can be used to directly infer the effect C 2009, The International Biometric Society 1203 of covariates on the quantile residual lifetimes at any specific time point, and that does not require specifying a semiparametric model for the underlying failure time. The proposed method can be viewed as a generalization of the median regression model (Ying, Jung, and Wei, 1995) . The interpretation of the larger quantile residual lifetime in a treatment group at time t 0 can be viewed as a positive effect of treatment on the quantile failure time among subjects who survived beyond t 0 . In general, evaluation of the asymptotic variance of the quantiles in survival data is not straightforward because it involves estimation of the probability density function of failure time distribution under censoring. Here we propose a method that deals directly with the estimating equation to avoid the problem.
In Section 2, some notations are introduced along with the definition of the quantile residual life function. In Section 3, a time-specific quantile residual life regression model is proposed. An estimating equation is formulated to estimate the regression parameters, and consistency and asymptotic normality of the regression estimator are established. An asymptotic χ 2 -statistic is also proposed to test significance of the regression parameters in this section. In Section 4, simulation studies are performed to assess the small-sample properties of the regression method, such as bias of the estimator, and type I error and power of the test statistic. In Section 5, the proposed method is applied to a data set from one of the earliest clinical trials on breast cancer treatment performed by the National Surgical Adjuvant Breast and Bowel Project (NSABP). We conclude with discussions in Section 6.
Quantile Residual Life Function
Let Y i , i = 1, 2 , . . . , n, denote the minimum of the failure time T i and censoring time C i . Let Δ i be the censoring indicator, i.e.,
Note that θ ξ | t is the ξ-quantile of the remaining lifetimes among patients who survived beyond time t. The function θ ξ | t has been extensively studied by many authors, including Schmittlein and Morrison (1981) , Arnold and Brockett (1983) , Csörgö and Horvath (1983) , Gupta and Langford (1984) , Joe and Proschan (1984) , Csörgö and Csörgö (1987) , Alam and Kulasekera (1993) , Song and Cho (1995) , among others. Gupta and Langford (1984) noted that θ ξ | t does not uniquely determine S(t) = P (T > t), but in practice one can model S(t) first and then infer θ ξ | t (Gelfand and Kottas, 2003) . Jeong, Jung, and Costantino (2008) developed a nonparametric twosample statistic to compare the median residual lifetimes at any fixed time point during the follow-up period of a study. In this article, we are particularly interested in associating the function θ ξ | t at a specific time t 0 , denoted as θ ξ | t 0 in the sequel, with selected covariates.
. . , n} are random samples from a single population. Let G(t) = P (C ≥ t) denote the "survival function" of censoring distribution, and I(·) is the indicator function. Since E{I(Y ≥ t)} = S(t)G(t) under the independence of failure and censoring times, we can consider an unbiased estimating function for θ ξ | t 0 ,
Here, G(t) is usually unknown, so that we replace it with its Kaplan-Meier estimator (Kaplan and Meier, 1958) , G(t) by using the censoring indicator 1 − Δ i , to obtain a consistent estimating function under censoring
Consistency and asymptotic normality of the solution θ ξ | t 0 to the equation can be easily developed.
In the following section, we extend the estimating equation for the quantile residual life for a single sample to a regression setting.
Regression Model
We consider a linear regression model for a ξ-quantile of residual lifetimes at time t 0 , on a log-scale,
where 
. Therefore the estimating function for noncensored case is given by
. Assuming conditional independence between T i and C i given Z i and independence of C i from Z i , the following is true for the censored data,
which is equivalent to
Under the model (3) and by definition of the ξ-quantile residual life function
Therefore,
) is approximately normal with mean zero and variance-covariance ma-
A consistent estimator Γ ξ | t 0 for the limiting covariance
which approximately follows a χ 2 -distribution with p + 1 degrees of freedom. A large observed value of this statistic suggests evidence against the null hypothesis H 0 . In Web Appendix C, we show that the distribution of β ξ | t 0 is asymptotically normal for given Z i and fixed t 0 based on the local linearity of S ξ | t 0 ,n (β ξ | t 0 ). Now we consider a partition of the regression coefficients,
are the corresponding estimates, and we are only interested in testing the hypothesis H 0 : β
ξ | t 0 , 0 , a specified vector, against a general alternative. For our test statistic, we will consider the minimum dispersion statistic (Basawa and Koul, 1988) ,
Note that evaluating this statistic does not require estimation of the probability density function of the survival distribution, which is needed for a Wald-type test statistic based on β ξ | t 0 . By using similar arguments given in Wei, Ying and Lin (1990, Web Appendix 2) and Ying et al. (1995, Web Appendix C) , it can be shown that (5) is approximately χ 2 -distributed with r degrees of freedom. We reject H 0 for a large value of
can be obtained as
where χ 2 r,1−α is the 100 × (1 − α)th percentile of a χ 2 -distribution with r degrees of freedom.
By using this result we can also estimate the prediction interval. From (3), the ξ-quantile residual lifetime for a patient with a covariate vector z 0 at time t 0 can be directly predicted by η(t 0 | z 0 ) = exp( β ξ | t 0 z 0 ). We estimate the associated 100(1 − α)% confidence interval by {η : Q(η) < χ 2 1, 1−α }, where
Simulation Studies
To assess the finite sample properties of our estimator and test statistic, simulation studies were performed based on the median residual regression, i.e., ξ = 1/2. For an easy interpretation of the results, we considered a simple model
where x 1i is a binary covariate, say, 0 for the control group and 1 for the treatment group. By the invariance property of the median with respect to monotone transformations, the model (8) is equivalent to
Here exp(β (0) t 0 ) and exp(β
) can be interpreted as the median residual lifetimes for the control and treatment groups at time t 0 , respectively, so that the difference in median residual lifetime between the two groups is given by exp β
In this case, note that the slope parameter β
can be interpreted as the logarithm of the ratio of the two median residual lifetimes at time point t 0 .
Failure times T i were assumed to follow a Weibull distribution with survival function S(t) = exp{−(ρt) κ }. For this distribution, note that under H 0 : β
= 0 the equations (1) and (9) give
Note that at the origin of time axis, i.e., t 0 = 0, ρ 0 = {log
0 ), where exp (β (0) 0 ) is the median of the failure distribution at t 0 = 0. By using the probability integral transformation, failure times were generated for both groups from T i = (1/ρ 0 ) {−log (1 − u i )} 1/ κ , where u i is from a uniform random variable between 0 and 1. Censoring times C i were generated from a uniform distribution between 0 and c, where constant c is for a certain censoring proportion. Finally the observed survival times Y i were determined as the minimum of T i and C i . We assumed that κ = 2 and exp (β via the mean and standard error (SE) of the parameter estimates. The grid search method was used to find the estimates that minimize the estimating equation (4). Table 1 summarizes the results. Although the proposed regression method needs to be used at one fixed time point, we have chosen various time points only for the purpose of comprehensive investigation in our simulation studies and real example. Under H 0 : β (11) gives the true values of β (0) t 0 as 1.61, 1.41, 1.22, and 1.04 at t 0 = 0, 1, 2, and 3, respectively. We assume that the shape parameter κ does not change in the surviving population. The true value of β (1) t 0 must be 0 for all t 0 ≥ 0 because an identical survival distribution was assumed for both groups. In Table 1 , New method MLE method In order to investigate the performance of our semiparametric estimator relative to the maximum likelihood (ML) approach, we also conducted a simulation study for the ML approach. The median residual life function for a subject i with a covariate x i at time t 0 is determined by θ i,
) are the true values of the regression parameters at t 0 and Z i = (1, x i ) . With a fixed value of κ, this implies
Denoting φ = (κ, β t 0 ), the log-likelihood function to estimate the vector φ is given by l(φ) =
We used the same simulation scenarios as before for a fair comparison. In Table 1 , we observe that the bias of the regression estimators by ML method is negligible across all scenarios. Their corresponding SEs of the estimates tend to increase in censoring proportion and t 0 . The bias and SE of the MLE are small overall. The bias of our semiparametric estimators is small with small t 0 values, but slightly increases with t 0 = 3. As expected, the MLE is more efficient than our estimator under the correct distributional assumption.
Next, with total sample sizes of n = 100, 200, or 1000, type I error probabilities for testing the null hypothesis H 0 : β (1) t 0 = 0(t 0 = 0, 1, 2, 3) with α = 0.05 were compared between the proposed and ML methods at various time points with different average censoring proportions ( Table 2 ). The results
Table 2
Type I error (1-95% coverage) probabilities for testing the null hypothesis H 0 : β Su and Wei (1993) , Ying et al. (1995) , and Jeong et al. (2008) . Similar settings were used for power analysis, except that the difference in median residual lifetimes between two groups were assumed to be 1, 3, and 5 at t 0 = 0. Note that when β 
where β (k ) 0 (k = 0, 1) is the true values of the regression parameters at t 0 = 0. The covariate values of x 1i being generated from a Bernoulli distribution with equal probability of success, failure times were simulated from
Note that the median of the failure distribution at t 0 = 0 is determined by
Equation (14) gives 5 when x 1i = 0, and it corresponds approximately to 6, 8, and 10, respectively, when x 1i = 1 and β
(1) 0 = 0.18, 0.47, and 0.69. Table 3 summarizes the probabilities of rejecting the null hypothesis of H 0 : β 
A Real Example
The NSABP B-04 data set has been chosen as a real data example because it has a long-term follow-up over 30 years, preserving important survival information among breast cancer patients without any chemo-or hormonal therapies after In the B-04 data, there were five groups being compared, three groups in node-negative patients and two groups in node-positive patients. With more than a quarter century of follow-up, the proportion of patients still alive is very low as expected, i.e., less than 30% among 1,079 eligible nodenegative patients with follow-up and less than 20% among 586 eligible node-positive patients with follow-up. Fisher et al. (2002) reported a 25-year follow-up update of the B-04 data. The original goal of the study was to prove that a less aggressive total mastectomy had an equivalent effect on patients' survival to the traditional radical mastectomy. In this article, the nodal status was considered as a covariate along with age at diagnosis of breast cancer and pathological tumor size to predict median residual lifetimes of breast cancer patients at any given time point.
First we consider a simple regression model that includes only one covariate of the nodal status, i.e., Z i = (1, X node,i ) , where X node,i was coded as 0 or 1 for node-negative and node-positive, respectively, in the regression model (3). Table 4a summarizes the estimates of β A comparison may be also considered between the proposed and proportional hazards regression models (Cox, 1972 (Cox, , 1975 Figure 2 represents such estimates from the NSABP B-04 data. The comparison indicates that the estimates from the proposed model seem to follow the path of the nonparametric one-sample estimates closer in each group than the Cox model does. The indication of lack of fit in the Cox model may be due to violation of the proportional hazards assumption in the B-04 data (p = 0.0002 by Grambsch and Therneau, 1994) .
In Figure 2 , we observe that the median residual lifetime of the node-positive group is shorter than that of the nodenegative group during the first 10 years. The median residual lifetime in the node-negative group is almost constant for the range of t 0 values. For the node-positive group, however, the median residual lifetime slightly increases in t 0 , which may imply that the node-positive patients tend to survive longer once they pass the early high-risk period. p-values and 95% confidence intervals from the minimum dispersion statistic (5) are provided in Table 4a to compare median residual lifetimes between the two nodal groups at each fixed time point t 0 . The results indicate that the nodal status has a significant effect on the median residual lifetimes in early time points, but the effect diminishes once patients survive more than 7 years. This is similar to the findings in Jeong et al. (2008) by using a two-sample test statistic without adjusting for other prognostic factors.
Since there are no other existing methods that can be directly compared with the proposed method, first we have adopted the bootstrap resampling method (Efron, 1979) to assess our results. We have resampled 1000 times from the original sample with replacement and calculated SEs of those 1000 estimates, which were 0.07, 0.10, 0.13, 0.14, 0.12, 0.11, and 0.16 for time points t = 0, 2, 4, 6, 7, 8, and 10, respectively. (Cox, 1972 (Cox, , 1975 was also chosen for a comparison of the observed significance of the slope parameter. In this case, the significance of the effect of nodal status was evaluated among surviving patients beyond each fixed time point. The results from the proportional hazards analysis are presented only through p-values for the comparison, because the quantities being evaluated are different under the proportional hazards and time-specific median residual life models. Note that the interpretation of the slope parameter is the logarithm of the hazard ratio under the proportional hazards model and the logarithm of the ratio of two median residual lifetimes at time t 0 under the proposed model, so that confidence intervals for the slope parameter from the two models cannot be compared directly. From Table 4a , we observe that the results from the three approaches are compatible in p-values, although ones from the proposed method tend to be slightly larger. We also see that the resampling and proposed methods give similar 95% confidence intervals. Now we consider the multiple regression model, where Z i = (1, X node,i , X age,i , X tsize,i ) , X node,i = 0 (node-negative) or 1 (node-positive), and both age (X age,i ) and pathological tumor size (X tsize,i ) are continuous covariates. The age and tumor size values were rescaled simply by multiplying by 0.01, so that the regularity condition holds in the estimates G(·) in the estimating equation (4). Table 4b shows the estimated regression parameters and corresponding 95% confidence intervals from the minimum dispersion statistic for testing 0, 2, 4, 6, 8, 10, cov = node, age, or tsize) . The results indicate that the negative effect of age at a diagnosis of cancer on the median residual lifetimes tends to become stronger for later time points, whereas the effects of nodal status and pathological tumor size are significant only up to first 4 or 5 years, when adjusting for other covariates.
These results can be used to predict a patient's median residual lifetime at a given time t 0 . For example, for a patient with positive lymph nodes, age at diagnosis of 56 (median), and pathological tumor size of 30mm (median), the median residual lifetime (in years) of 6 years after the original diagnosis of cancer can be predicted as exp{3.92 − 1 × 0.28 − 2.11 × (0.01 × 56.0) − 0.48 × (0.01 × 30.0)} = 10.1. Similarly for node-negative patients, the predicted median residual lifetime is 13.4 years. From (7), the corresponding 95% prediction intervals are (7.3,12.9) and (11.2,16.4), respectively. These estimates may be used as baseline mortality information for a future clinical study to evaluate a new therapy in terms of prolonging the patients' remaining lifetimes.
Discussion
In this article, we proposed a regression model on quantile residual lifetimes, where the covariate effects can be directly associated with the quantile failure time among survivors beyond any specific time point, rather than inferring the quantile residual lifetime under some global regression model assumptions such as proportional hazards or AFT. An estimating equation for the regression coefficients has been formulated and justified under the proposed model. Asymptotic distributions of the proposed regression parameter estimator and test statistic to evaluate the covariate effects have been derived, and it was shown that they had reasonable finite sample properties through simulation studies. The grid search method that was used to find the roots of the estimating equation also provided reasonable solutions in our simulation studies and real example. The variance of the proposed estimators depends on the probability density function of the survival variables. However, the variance of the estimating function can be consistently estimated without specification of the survival distribution. Hence, we used the minimum dispersion statistic (Basawa and Koul, 1988) based on the distribution of the estimating function. The variance of the regression coefficient estimator may be estimated by using either the proposed confidence interval approach or the bootstrap resampling method.
Our theoretical results in Section 3 are based on the uniform consistency of the Kaplan-Meier estimator S(t) over 0 < t < ζ = sup{t : S(t)G(t) > 0}, which leads to a condition that t 0 + exp(β ξ | t 0 Z) < ζ in our case. Here ζ may be considered as the maximum follow-up time, which has the lower bound t 0 + exp(β ξ | t 0 Z).
As noted in Ying et al. (1995) , to check the model assumption of ({3) at a fixed time t 0 , a zero-mean Gaussian process of cumulative sums of median residuals can be defined as
, where
G(t 0 )
.
A plot of W(s) against the predicted ξ-quantile residual lifetimes may be used as a graphical tool to check the model assumption at time t 0 . We have assumed that survival and censoring variables are conditionally independent given covariates. By using a censoring distribution model that is independent of covariates, however, the conditional independence assumption is reduced to an unconditional independence assumption, as a referee pointed out. The latter stronger assumption holds for most well-conducted clinical trials, including the NSABP trial discussed in this article, where the major cause of censoring is administrative. If the censoring distribution depends on a discrete covariate, we may partition the data into a number of strata defined by the covariate values so that the censoring variables have an identical distribution within each stratum. If the censoring distribution depends on a continuous covariate, we may consider modeling the dependency of censoring distribution on the covariate. For example, for a continuous covariate z i , suppose that C i satisfies a proportional hazards model h i (t) = h 0 (t) exp (γz i ), where h i (t) is the hazard function of C i and h 0 (t) is the baseline hazard function. Then, G(t) in (4) will be replaced by G(t | z i ) = exp{− h 0 (t) exp( γz i )}, where γ is the partial MLE (Cox, 1972) for the censoring distribution and h 0 (t) is the Breslow's (1974) estimator of h 0 (t). If the assumed censoring model is correct, the consistency and asymptotic normality of β ξ | t 0 can be derived using the properties of γ.
An associate editor raised an issue regarding how to choose quantiles and how to interpret the results if the covariate effects differ across quantiles. In theory, any quantile ξ such that ξ < { S(t 0 ) − S(t m a x )}/ S(t 0 ), where t max = max (X i ) and X i = min(T i , C i ), can be chosen, but one closer to the middle is recommended due to less variability. In the same context, the interpretation with one toward the middle should be considered more reliable. In practice, however, determination of which quantiles to be investigated would also depend on the scientific objectives of the study. For example, if the investigator is interested in inferring a patient population with longer survival, high quantiles such as 80 or 90 percentile, rather than the median, would be more appropriate. We have reanalyzed the NSABP B-04 data across different quantiles at t 0 = 0 in the simple regression model. For the 10th, 25th, 50th, and 75th percentile models, the estimates of the slope parameter were −0.620, −0.623, −0.620, and −0.351, respec- tively, all of which were associated with the p-value smaller than 0.0001. Thus the interpretation of the effect of the nodal status on patients' survival does not change for the use of different quantiles in this example.
Supplementary Materials
The proofs of consistency and asymptotic normality of β ξ | t 0 and asymptotic normality of n −1/ 2 S ξ | t 0 ,n (β 0 ξ | t 0 ) in Section 3 are available under the Paper Information link at the Biometrics website http://www.biometrics.tibs.org.
